المؤلفون: Gursoy P., Tatli A.M., Erdem D., Goker E., Celik E., Demirci N.S., Sakin A.

مصطلحات موضوعية: Afatinib, Erlotinib, Exon 18, Exon 20, NSCLC, epidermal growth factor receptor, gefitinib, EGFR protein, human, protein kinase inhibitor, quinazoline derivative, adult, anemia, Article, cancer chemotherapy, cancer resistance, cancer survival, comparative study, controlled study, diarrhea, drug withdrawal, female, follow up, hypertransaminasemia, interstitial lung disease, major clinical study, male, middle aged, mucosa inflammation, multicenter study

العلاقة: Journal of Cancer Research and Clinical Oncology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.1007/s00432-022-03984-5Test; https://hdl.handle.net/20.500.12831/19454Test; 149; 865; 875; 2-s2.0-85127494466

الإتاحة: https://doi.org/10.1007/s00432-022-03984-5Test
https://doi.org/20.500.12831/19454Test
https://hdl.handle.net/20.500.12831/19454Test

المؤلفون: Tanriverdi, O., Menekse, S., Dogan, M., Hacioglu, B., Oktay, E., Erdem, D., Degirmencioglu, Serkan.

مصطلحات موضوعية: mucosa inflammation, Colorectal cancer, Bevacizumab, Kras, Metastatic, Panitumumab, cetuximab, fluorouracil, folinic acid, irinotecan, K ras protein, oxaliplatin, antineoplastic agent, KRAS protein, human, protein p21, acute kidney failure, adult, aged, anemia, Article, blood transfusion, cancer combination chemotherapy, cancer immunotherapy, cancer prognosis, cancer survival, colorectal carcinoma, constipation, controlled study, deep vein thrombosis

العلاقة: Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/11499/30529Test; 24; 242; 248; 2-s2.0-85062401719; WOS:000458202600033

الإتاحة: https://hdl.handle.net/11499/30529Test

المؤلفون: Meyskens, F L, Jr, Kopecky, K J, Appelbaum, F R, Balcerzak, S P, Samlowski, W, Hynes, H

المصدر: Leukemia research. 19(9)

مصطلحات موضوعية: Antineoplastic Agents, Alkylating: administration & dosage, Blast Crisis, Busulfan: administration & dosage, Female, Humans, Leukemia, Myelogenous, Chronic, BCR-ABL Positive: drug therapy, Male, Middle Aged, Survival Analysis, Vitamin A: administration & dosage, busulfan, Chronic myelogenous leukemia, differentiation, retinoids, vitamin Abusulfan, retinol, abdominal cramp, adult, alopecia, anemia, anorexia, article, bone pain, chronic myeloid leukemia, clinical trial, controlled clinical trial, controlled study, diarrhea, drug hypersensitivity, esophagus ulcer, fatigue, female, gastrointestinal symptom, headache, hot flush, human, hyperpigmentation, leukocyte count, leukopenia, liver dysfunction, major clinical study, male, mucosa inflammation, myalgia, nausea, neurologic disease, oral drug administration, personality disorder, priority journal, prothrombin time, randomized controlled trial, stomach ulcer, thrombocyte count, thrombocytopenia, vertigo, vomiting, weight reduction, xerostomia, Antineoplastic Agents, Alkylating, Blast Crisis, Busulfan, Female, Humans, Leukemia, Myeloid, Chronic, Leukemia, Myeloid, Philadelphia-Positive, Male, Middle Aged, Survival Analysis, Vitamin A

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/44q9g8b2Test

المؤلفون: Tuinmann, G., Preissler, P., Böhmer, H., Suling, A., Bokemeyer, C.

المصدر: MHI Citations

مصطلحات موضوعية: EMBASE keywords, anemia, anxiety, autologous stem cell transplantation, cancer chemotherapy, CD4 lymphocyte count, CD8 lymphocyte count, controlled study, depression, diarrhea, drug megadose, Hodgkin disease, human, hypokalemia, infection, leukemia, liver toxicity, loss of appetite, lymphocyte count, major clinical study, mucosa inflammation, multiple myeloma, natural killer cell count, nausea, neutropenia, nociception, nonhodgkin lymphoma, pain, pilot study, quality of life

العلاقة: https://remix.berklee.edu/mhi-citations/503Test; https://doi.org/10.1002/pon.4142Test

الإتاحة: https://doi.org/10.1002/pon.4142Test
https://remix.berklee.edu/mhi-citations/503Test

المؤلفون: Oya Karadağ, Esat Mahmut Özşahin, Candan Demiröz, Günhan Cebelli, Lütfi Özkan

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı., Demiröz, Candan, Özkan, Lütfi, Karadağ, Oya

المصدر: Turkiye Klinikleri Journal of Medical Sciences. 32:1207-1216

مصطلحات موضوعية: Male, Oncology, medicine.medical_treatment, Skin manifestation, Amifostine, 2 (3 Aminopropylamino)Ethanethiol, Radioprotective Effect, Cancer growth, Overall survival, Subcutaneous amifostine, Head and neck cancer, Drug tolerability, Drug withdrawal, Radiation dose, Radiation hazard, Dose radioiodine treatment, Salivary-glands, Anemia, Nausea, Dysphagia, General Medicine, Medicine, general & internal, Cancer radiotherapy, Distant metastasis, Female, Cancer chemotherapy, Hypotension, Human, medicine.drug, Adult, Amifostin, medicine.medical_specialty, Squamous-cell carcinoma, Radyoterapi, Vomiting, Drug response, Hyperfractionated radiotherapy, Major clinical study, Xerostomia, Article, Syncope, Treatment duration, Mucosa inflammation, Locally advanced head, Internal medicine, Concomitant-boost, medicine, Multimodality cancer therapy, Radiation injury, Aged, Randomized phase-II, Radiotherapy, business.industry, Follow up, Leukopenia, Baş ve boyun kanseri, medicine.disease, Fibrosis, Thrombocytopenia, Cancer survival, Drug effect, Radiation therapy, Drug efficacy, Outcome assessment, Kserostomi, Therapy, General & internal medicine, Cisplatin, business, Controlled study, Drug eruption

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b73b1ff5101f780339d3d75ddc4e58fbTest
https://doi.org/10.5336/medsci.2011-23100Test

المؤلفون: Osman Manavoglu, Ekrem Kaya, Lütfi Özkan, Meral Kurt, Sevilcan Aygun, Turkkan Evrensel, Tulay Palazoglu, Ozkan Kanat, Ender Kurt, Sibel Kahraman Çetintaş

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Radyasyon Onkolojisi Anabilim Dalı., Uludağ Üniversitesi/Tıp Fakültesi/Cerrahisi Anabilim Dalı., Kurt, Ender, Kurt, Meral, Kanat, Özkan, Çetintaş, Sibel Kahraman, Aygun, Sevilcan, Palazoğlu, Julay, Özkan, Lütfi, Evrensel, Türkkan, Kaya, Ekrem, Manavoğlu, Osman, AAJ-1027-2021, AAG-7319-2021, AAA-7047-2020, AAA-3961-2020

المصدر: Tumori Journal. 92:481-486

مصطلحات موضوعية: Male, Oncology, Cancer Research, Survival, medicine.medical_treatment, Phases of clinical research, Kaplan-Meier Estimate, Treatment response, Deoxycytidine, Gastroenterology, Trial, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Controlled clinical trial, Antineoplastic Combined Chemotherapy Protocols, Disease course, Pancreas cancer, Remission Induction, Anemia, Nausea, Chemoradiotherapy, General Medicine, Middle Aged, Clinical trial, Treatment Outcome, Chemoradiation, Tolerability, Chemotherapy, Adjuvant, Fluorouracil, Cancer radiotherapy, 030220 oncology & carcinogenesis, Induction chemotherapy, Combination, Drug dose reduction, Female, Human, medicine.drug, Adult, Diarrhea, medicine.medical_specialty, Neutropenia, Duodenum ulcer, Clinical article, External beam radiotherapy, 130-Nm Albumin-Bound Paclitaxel, Gemcitabine, Pancreatic Neoplasms, Disease-Free Survival, Article, 03 medical and health sciences, Mucosa inflammation, Advanced cancer, Internal medicine, Gfluorouracil, medicine, Humans, Phase 2 clinical trial, Neoplasm Staging, Aged, Chemotherapy, Radiotherapy, business.industry, Carcinoma, Resection, medicine.disease, Thrombocytopenia, Cancer survival, Cancer combination chemotherapy, Cooperative-oncology-group, Radiation-therapy, Radiotherapy, Adjuvant, Dose Fractionation, Radiation, Pancreatic carcinoma, Bolus injection, business, Controlled study

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6491eed56d4066e3a4d228bf69488020Test
https://doi.org/10.1177/030089160609200603Test

المؤلفون: Murat Arslan, Ender Kurt, Guzin Gonullu, Mutlu Demiray, Ozkan Kanat, Osman Manavoglu, Turkkan Evrensel

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Bilim Dalı., Kanat, Özkan, Evrensel, Türkkan, Kurt, Ender, Demiray, Mutlu, Gönüllü, Güzin, Arslan, Murat, Manavoğlu, Osman, AAJ-1027-2021, M-8060-2019

المصدر: Tumori Journal. 90:192-195

مصطلحات موضوعية: Male, Oncology, Cancer Research, Phases of clinical research, Single Center, Deoxycytidine, Gastroenterology, Trial, Metastasis, 030218 nuclear medicine & medical imaging, 0302 clinical medicine, Bolus (medicine), Antineoplastic Combined Chemotherapy Protocols, 5-fluorouracil, Pancreas cancer, Survival time, Drug tolerability, Analgesics, Leukopenia, Anemia, Pancreas Adenocarcinoma, Gemcitabine, Pancreatic Neoplasms, General Medicine, Middle Aged, Serotonin 3 antagonist, Clinical trial, Treatment Outcome, Fluorouracil, 030220 oncology & carcinogenesis, Injections, Intravenous, Disease Progression, Female, medicine.symptom, Human, medicine.drug, Adult, Diarrhea, Antimetabolites, Antineoplastic, medicine.medical_specialty, Clinical article, Drug response, Adenocarcinoma, Drug Administration Schedule, Article, Drug toxicity, 03 medical and health sciences, Mucosa inflammation, Internal medicine, medicine, Mucositis, Humans, Chemotherapy, High-dose leucovorin, Phase 2 clinical trial, Aged, business.industry, Body Weight, Pancreatic cancer, medicine.disease, Survival Analysis, Thrombocytopenia, Cancer survival, Cancer combination chemotherapy, Drug effect, Drug efficacy, Regimen, Tract cancer, Antiemetic agent, business

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb1e7af86667f6cfc6f7a594cb91f8e8Test
https://doi.org/10.1177/030089160409000206Test

المؤلفون: Aravantinos, Gerasimos, Bafaloukos, Dimitrios, Fountzilas, George, Christodoulou, C., Papadimitriou, C., Pavlidis, Nicholas, Kalofonos, H. P., Gogas, H., Kosmidis, Paraskevas A., Dimopoulos, M. A.

المساهمون: Pavlidis, Nicholas [0000-0002-2195-9961], Aravantinos, Gerasimos [0000-0002-2106-1713], Kalofonos, H. P. [0000-0002-3286-778X]

المصدر: Annals of Oncology

مصطلحات موضوعية: medicine.medical_treatment, Docetaxel, Skin disease, Gastroenterology, Carboplatin, Granulocyte colony-stimulating factor, Antineoplastic agents, Antineoplastic Combined Chemotherapy Protocols, Granulocyte Colony-Stimulating Factor, Prospective Studies, Treatment outcome, Drug safety, Etoposide, Ovarian Neoplasms, Multicenter study, Clinical trial, Oxaliplatin, Local, Oncology, Vertigo, Disease Progression, Taxoids, Infection, Human, Diarrhea, Neoplasm recurrence, medicine.medical_specialty, Bone marrow suppression, Paclitaxel, Clinical article, Febrile neutropenia, Antineoplastic Agents, Methylprednisolone, Article, Disease-Free Survival, Ovarian cancer, Humans, Platinum-resistant, Cancer recurrence, Aged, Disease progression, Drug infusion, Recombinant granulocyte colony stimulating factor, Follow up, Myalgia, Leukopenia, Monotherapy, medicine.disease, Cancer combination chemotherapy, Drug effect, Regimen, Drug resistance, Cisplatin, Ovarian neoplasms, Controlled clinical trial, Nausea and vomiting, Phytogenic, Middle aged, Fatigue, Priority journal, Platinum derivative, Anemia, Vinorelbine, Hematology, Middle Aged, Arthralgia, Ondansetron, Anorexia, Treatment Outcome, Drug choice, Female, medicine.symptom, medicine.drug, Adult, Abdominal pain, Neutropenia, Ovary cancer, Disease-free survival, Navelbine, Vinblastine, Mucosa inflammation, Antineoplastic combined chemotherapy protocols, Internal medicine, Neurotoxicity, medicine, Chemotherapy, Phase 2 clinical trial, Stomatitis, business.industry, Alopecia, Taxane derivative, Gemcitabine, Thrombocytopenia, Antineoplastic Agents, Phytogenic, Cancer survival, Surgery, Drug efficacy, Doxorubicin, Drug Resistance, Neoplasm, Neoplasm, Neoplasm Recurrence, Local, Antiemetic agent, Topotecan, business, Controlled study, Constipation, Prospective studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e836ea784e7dd1d62801cbb6bcc90bTest
https://doi.org/10.1093/annonc/mdg292Test

المؤلفون: Van Gestel, D., Verellen, D., Van de Voorde, L., Deost, B., De Kerf, G., Vanderveken, O., Van Laer, C., Van Denweyngaert, D., Vermorken, J.B., Grégoire, Vincent

المساهمون: UCL - SSS/IREC/MIRO - Pôle d'imagerie moléculaire, radiothérapie et oncologie, UCL - (SLuc) Service de radiothérapie oncologique

المصدر: Oncologist, Vol. 18, no.6, p. 697-706 (2013)

مصطلحات موضوعية: Head and neck cancer, Human, Intensity modulated radiation therapy, Leukopenia, Linear accelerator, Mucosa inflammation, Neutropenia, Nuclear magnetic resonance imaging, Photon therapy, Positron emission tomography, Helical tomotherapy, Priority journal, Radiosensitivity, Randomized controlled trial (topic), Skin disease, Stomatitis, Tomotherapy, Tumor volume, Vomiting, Xerostomia, Algorithm, Anemia, Article, Clinical practice, Computer assisted tomography, Cone beam computed tomography, Dysphagia

العلاقة: boreal:135364; http://hdl.handle.net/2078.1/135364Test; urn:ISSN:1083-7159

الإتاحة: https://doi.org/10.1634/theoncologist.2012-0424Test
http://hdl.handle.net/2078.1/135364Test

المؤلفون: O'Neil, Bert H.

المساهمون: Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı., Kanat, Özkan

مصطلحات موضوعية: Continuous infusion, Drug targeting, Survival rate, Cetuximab, Gimeracil plus oteracil potassium plus tegafur, Docetaxel, Review, Medical decision making, Treatment response, Metastasis, Gastroesophageal junction adenocarcinoma, Multiple cycle treatment, Randomized controlled trial (topic), Targeted treatment, Pathology, Drug fatality, Overall survival, Treatment outcome, Etoposide, Priority journal, Survival time, Drug tolerability, Panitumumab, Folinic acid, Anemia, Nausea, Immunohistochemistry, Esophagus cancer, Chemotherapy-naive patients, Bevacizumab, Oxaliplatin, Europe, Clinical trial (topic), Oncology, Antineoplastic agent, Decreased appetite, Molecularly targeted therapy, Drug dose reduction, Fluorouracil, Human, Diarrhea, Drug megadose, Quality of life, Asia, Neutropenia, Plus cisplatin, Stomach cancer, Febrile neutropenia, Drug delivery system, Antiangiogenic therapy, Hypokalemia, Cancer mortality, Cause of death, Stomach tumor, Irinotecan, Epidermal growth factor receptor 2, Targeted therapies, Stomach perforation, Mucosa inflammation, 1st-line treatment, Rash, Thromboembolism, Chemotherapy, Everolimus, Gene mutation, Phase 3 clinical trial (topic), Ramucirumab, Rivoceranib, Line, Capecitabine, Placebo, Epirubicin, Cancer prognosis, Stomatitis, Vasculotropin, Oncogene K ras, Vasculotropin receptor 1, Phase-II trial, Trastuzumab, Vasculotropin receptor 2, Monotherapy, Metastatic stomach cancer, Multicenter study (topic), Cancer survival, Cancer combination chemotherapy, Methotrexate, Clinical effectiveness, Acne, Doxorubicin, Progression free survival, Protein expression, Cisplatin, Gastric cancer, Prognostic model, Phase 2 clinical trial (topic), Phosphatidylinositol 3 kinase

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=od______9458::c357870bd9aace288f11f0f0c08d1514Test
http://hdl.handle.net/11452/27330Test